Mechanism of Yangxinkang Tablet in Inhibiting Cardiomyocyte Apoptosis in Rabbit with Heart Failure After Myocardial Infarction Through Akt/AMPK-mTOR Pathway
REN Pei-hua, WANG Peng, LIAO Dong-jiang, et al. Mechanism of Yangxinkang Tablet in Inhibiting Cardiomyocyte Apoptosis in Rabbit with Heart Failure After Myocardial Infarction Through Akt/AMPK-mTOR Pathway[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(16): 124-130.
REN Pei-hua, WANG Peng, LIAO Dong-jiang, et al. Mechanism of Yangxinkang Tablet in Inhibiting Cardiomyocyte Apoptosis in Rabbit with Heart Failure After Myocardial Infarction Through Akt/AMPK-mTOR Pathway[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(16): 124-130. DOI: 10.13422/j.cnki.syfjx.20181533.
Objective: To observe the effect of Yangxinkang tablet on cardiomyocyte apoptosis in rabbit with heart failure after myocardial infarction through protein kinase B (Akt)/AMP-activated kinase (AMPK)-the mammalian target of rapamycin (mTOR) pathway. Method: The rabbit model of heart failure was established through ligation of coronary artery. A total of 30 experimental animals were randomly divided into model group
Yangxinkang group
AMPK inhibitor group (10 mg·kg-1 Compound C
intraperitoneal injection
2 times a day)
Akt inhibitor group (10 mg·kg-1 casodex
intragastric administration
2 times a day) and mTOR inhibitor group (0.5 mg·kg-1 rapamycin
intragastric administration
2 times a day)
and a blank control group was also set up
with 5 in each group. Yangxinkang tablet (0.51 g·kg-1) were intragastrically administered once a day. Blank control group and experimental groups were given the equivalent volume of distilled water for 4 weeks. Heart function was detected by color Doppler ultrasound
Bcl-2 and Bax protein expressions were detected by Western blot
and cardiomyocyte apoptosis was detected by TdT-mediated DUTP nick end labeling(TUNEL). Result: Compared with the blank control group
the LVEF value of the model group decreased (P<0.01)
the expressions of Bcl-2 and Bax protein increased (P<0.05
P<0.01)
the Bcl-2/Bax ratio decreased (P<0.01)
and cardiomyocyte apoptosis rate was increased (P<0.01). Compared with the model group
the LVEF value of the Yangxinkang group was increased (P<0.01)
the expression of Bax protein was decreased (P<0.01)
the Bcl-2/Bax ratio was increased (P<0.01)
and the cardiomyocyte apoptosis rate was decreased (P<0.01). Compared with each inhibitor groups
the LVEF value of Yangxinkang group was increased (P<0.01)
Bcl-2/Bax ratio was increased (P<0.01)
and the cardiomyocyte apoptosis rate was decreased (P<0.01). Conclusion: Yangxinkang tablet can regulate the expressions of Bcl-2 and Bax protein in cardiac myocytes
reduce cardiomyocyte apoptosis through Akt/AMPK-mTOR pathway and improve the cardiac function of heart failure model after myocardial infarction.